WO2007069841A1 - Procede de preparation de cyclopropane carboxamide optiquement actif, et de ses derives - Google Patents
Procede de preparation de cyclopropane carboxamide optiquement actif, et de ses derives Download PDFInfo
- Publication number
- WO2007069841A1 WO2007069841A1 PCT/KR2006/005402 KR2006005402W WO2007069841A1 WO 2007069841 A1 WO2007069841 A1 WO 2007069841A1 KR 2006005402 W KR2006005402 W KR 2006005402W WO 2007069841 A1 WO2007069841 A1 WO 2007069841A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- substituted
- carboxylic acid
- acid ester
- unsubstituted
- cyclopropane
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 21
- AIMMVWOEOZMVMS-UHFFFAOYSA-N cyclopropanecarboxamide Chemical compound NC(=O)C1CC1 AIMMVWOEOZMVMS-UHFFFAOYSA-N 0.000 title claims abstract description 18
- 238000006243 chemical reaction Methods 0.000 claims description 36
- YMGUBTXCNDTFJI-UHFFFAOYSA-N cyclopropanecarboxylic acid Chemical compound OC(=O)C1CC1 YMGUBTXCNDTFJI-UHFFFAOYSA-N 0.000 claims description 29
- 108090001060 Lipase Proteins 0.000 claims description 25
- 239000004367 Lipase Substances 0.000 claims description 25
- 102000004882 Lipase Human genes 0.000 claims description 25
- 235000019421 lipase Nutrition 0.000 claims description 25
- 241001661345 Moesziomyces antarcticus Species 0.000 claims description 20
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 12
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 12
- 239000003960 organic solvent Substances 0.000 claims description 12
- -1 di- fluoromethyl Chemical group 0.000 claims description 10
- 125000000217 alkyl group Chemical group 0.000 claims description 9
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 claims description 8
- 229910052739 hydrogen Inorganic materials 0.000 claims description 8
- 239000001257 hydrogen Substances 0.000 claims description 8
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 6
- 125000003342 alkenyl group Chemical group 0.000 claims description 6
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 6
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 6
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 6
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 6
- 125000004446 heteroarylalkyl group Chemical group 0.000 claims description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 6
- KBPLFHHGFOOTCA-UHFFFAOYSA-N 1-Octanol Chemical compound CCCCCCCCO KBPLFHHGFOOTCA-UHFFFAOYSA-N 0.000 claims description 4
- BBMCTIGTTCKYKF-UHFFFAOYSA-N 1-heptanol Chemical compound CCCCCCCO BBMCTIGTTCKYKF-UHFFFAOYSA-N 0.000 claims description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 4
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 4
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 claims description 4
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 claims description 4
- 125000004216 fluoromethyl group Chemical group [H]C([H])(F)* 0.000 claims description 4
- ZSIAUFGUXNUGDI-UHFFFAOYSA-N hexan-1-ol Chemical compound CCCCCCO ZSIAUFGUXNUGDI-UHFFFAOYSA-N 0.000 claims description 4
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 claims description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 4
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 4
- 125000003545 alkoxy group Chemical group 0.000 claims description 3
- 125000001028 difluoromethyl group Chemical group [H]C(F)(F)* 0.000 claims description 3
- 229910052736 halogen Inorganic materials 0.000 claims description 3
- 150000002367 halogens Chemical class 0.000 claims description 3
- BGJSXRVXTHVRSN-UHFFFAOYSA-N 1,3,5-trioxane Chemical compound C1OCOCO1 BGJSXRVXTHVRSN-UHFFFAOYSA-N 0.000 claims description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 2
- SUAKHGWARZSWIH-UHFFFAOYSA-N N,N‐diethylformamide Chemical compound CCN(CC)C=O SUAKHGWARZSWIH-UHFFFAOYSA-N 0.000 claims description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 claims description 2
- 125000005997 bromomethyl group Chemical group 0.000 claims description 2
- 125000004218 chloromethyl group Chemical group [H]C([H])(Cl)* 0.000 claims description 2
- 125000004772 dichloromethyl group Chemical group [H]C(Cl)(Cl)* 0.000 claims description 2
- 125000005745 ethoxymethyl group Chemical group [H]C([H])([H])C([H])([H])OC([H])([H])* 0.000 claims description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 2
- 125000004184 methoxymethyl group Chemical group [H]C([H])([H])OC([H])([H])* 0.000 claims description 2
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 2
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 claims description 2
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 2
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 2
- TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 claims description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims description 2
- 125000003866 trichloromethyl group Chemical group ClC(Cl)(Cl)* 0.000 claims description 2
- 239000008096 xylene Substances 0.000 claims description 2
- 150000002431 hydrogen Chemical class 0.000 claims 3
- 102000004190 Enzymes Human genes 0.000 abstract description 27
- 108090000790 Enzymes Proteins 0.000 abstract description 27
- 230000003287 optical effect Effects 0.000 description 50
- 238000000034 method Methods 0.000 description 23
- 238000006911 enzymatic reaction Methods 0.000 description 13
- YBZQRYWKYBZZNT-SCSAIBSYSA-N (1s)-2,2-dimethylcyclopropane-1-carboxamide Chemical compound CC1(C)C[C@@H]1C(N)=O YBZQRYWKYBZZNT-SCSAIBSYSA-N 0.000 description 11
- 238000001953 recrystallisation Methods 0.000 description 9
- 230000002255 enzymatic effect Effects 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 239000000758 substrate Substances 0.000 description 8
- VEQMUQZKBLIXLT-UHFFFAOYSA-N 2,3-dimethylcyclopropane-1-carboxylic acid Chemical compound CC1C(C)C1C(O)=O VEQMUQZKBLIXLT-UHFFFAOYSA-N 0.000 description 7
- 150000001298 alcohols Chemical class 0.000 description 7
- 239000003153 chemical reaction reagent Substances 0.000 description 7
- 150000001875 compounds Chemical class 0.000 description 7
- 239000000047 product Substances 0.000 description 6
- 239000000203 mixture Substances 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 108090000371 Esterases Proteins 0.000 description 4
- LOUPRKONTZGTKE-WZBLMQSHSA-N Quinine Chemical compound C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-WZBLMQSHSA-N 0.000 description 4
- 150000001412 amines Chemical class 0.000 description 4
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- 125000001424 substituent group Chemical group 0.000 description 4
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 4
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 3
- RMVIMWRFBQNSKR-UHFFFAOYSA-N 2-bromoethyl 2,2-dimethylcyclopropane-1-carboxylate Chemical compound CC1(C)CC1C(=O)OCCBr RMVIMWRFBQNSKR-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- RHQDFWAXVIIEBN-UHFFFAOYSA-N Trifluoroethanol Chemical compound OCC(F)(F)F RHQDFWAXVIIEBN-UHFFFAOYSA-N 0.000 description 3
- 230000036983 biotransformation Effects 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 239000011259 mixed solution Substances 0.000 description 3
- KPWDGTGXUYRARH-UHFFFAOYSA-N 2,2,2-trichloroethanol Chemical compound OCC(Cl)(Cl)Cl KPWDGTGXUYRARH-UHFFFAOYSA-N 0.000 description 2
- QXUCJWJDQBHKOM-UHFFFAOYSA-N 2,2,2-trichloroethyl 2,2-dimethylcyclopropane-1-carboxylate Chemical compound CC1(C)CC1C(=O)OCC(Cl)(Cl)Cl QXUCJWJDQBHKOM-UHFFFAOYSA-N 0.000 description 2
- JLTBCXJPWXTLEJ-UHFFFAOYSA-N 2,2,2-trifluoroethyl 2,2-dimethylcyclopropane-1-carboxylate Chemical compound CC1(C)CC1C(=O)OCC(F)(F)F JLTBCXJPWXTLEJ-UHFFFAOYSA-N 0.000 description 2
- YHKJSIVFPYFAJL-UHFFFAOYSA-N 2,2,2-trifluoroethyl cyclopropanecarboxylate Chemical class FC(F)(F)COC(=O)C1CC1 YHKJSIVFPYFAJL-UHFFFAOYSA-N 0.000 description 2
- RXMTUVIKZRXSSM-UHFFFAOYSA-N 2,2-diphenylethanamine Chemical compound C=1C=CC=CC=1C(CN)C1=CC=CC=C1 RXMTUVIKZRXSSM-UHFFFAOYSA-N 0.000 description 2
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 2
- LDLCZOVUSADOIV-UHFFFAOYSA-N 2-bromoethanol Chemical compound OCCBr LDLCZOVUSADOIV-UHFFFAOYSA-N 0.000 description 2
- SZIFAVKTNFCBPC-UHFFFAOYSA-N 2-chloroethanol Chemical compound OCCCl SZIFAVKTNFCBPC-UHFFFAOYSA-N 0.000 description 2
- QLLRZRXEQPAGQA-UHFFFAOYSA-N 2-chloroethyl 2,2-dimethylcyclopropane-1-carboxylate Chemical compound CC1(C)CC1C(=O)OCCCl QLLRZRXEQPAGQA-UHFFFAOYSA-N 0.000 description 2
- LPTHEVLJSVAPLO-UHFFFAOYSA-N 2-methoxyethyl 2,2-dimethylcyclopropane-1-carboxylate Chemical compound COCCOC(=O)C1CC1(C)C LPTHEVLJSVAPLO-UHFFFAOYSA-N 0.000 description 2
- 235000001258 Cinchona calisaya Nutrition 0.000 description 2
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 239000012320 chlorinating reagent Substances 0.000 description 2
- LOUPRKONTZGTKE-UHFFFAOYSA-N cinchonine Natural products C1C(C(C2)C=C)CCN2C1C(O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-UHFFFAOYSA-N 0.000 description 2
- 230000032050 esterification Effects 0.000 description 2
- 238000005886 esterification reaction Methods 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 229940041616 menthol Drugs 0.000 description 2
- 239000011368 organic material Substances 0.000 description 2
- 229960000948 quinine Drugs 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 230000009257 reactivity Effects 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 230000000707 stereoselective effect Effects 0.000 description 2
- OZQIGRHPBIWVGU-UHFFFAOYSA-N 2,2,2-trifluoroethyl 2,3-dimethylcyclopropane-1-carboxylate Chemical compound FC(COC(=O)C1C(C1C)C)(F)F OZQIGRHPBIWVGU-UHFFFAOYSA-N 0.000 description 1
- OGZJULUCZAZKHP-UHFFFAOYSA-N 2,2-dibromoethanol Chemical compound OCC(Br)Br OGZJULUCZAZKHP-UHFFFAOYSA-N 0.000 description 1
- IDJOCJAIQSKSOP-UHFFFAOYSA-N 2,2-dichloroethanol Chemical compound OCC(Cl)Cl IDJOCJAIQSKSOP-UHFFFAOYSA-N 0.000 description 1
- VOGSDFLJZPNWHY-UHFFFAOYSA-N 2,2-difluoroethanol Chemical compound OCC(F)F VOGSDFLJZPNWHY-UHFFFAOYSA-N 0.000 description 1
- YBZQRYWKYBZZNT-UHFFFAOYSA-N 2,2-dimethylcyclopropane-1-carboxamide Chemical compound CC1(C)CC1C(N)=O YBZQRYWKYBZZNT-UHFFFAOYSA-N 0.000 description 1
- BFNMOMYTTGHNGJ-UHFFFAOYSA-N 2,2-dimethylcyclopropane-1-carboxylic acid Chemical compound CC1(C)CC1C(O)=O BFNMOMYTTGHNGJ-UHFFFAOYSA-N 0.000 description 1
- IDBOZJGFRCKBGY-UHFFFAOYSA-N 2,3-dimethylcyclopropane-1-carboxamide Chemical compound CC1C(C)C1C(N)=O IDBOZJGFRCKBGY-UHFFFAOYSA-N 0.000 description 1
- GGDYAKVUZMZKRV-UHFFFAOYSA-N 2-fluoroethanol Chemical compound OCCF GGDYAKVUZMZKRV-UHFFFAOYSA-N 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- 241000222175 Diutina rugosa Species 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- ITATYELQCJRCCK-UHFFFAOYSA-N Mandelic Acid, Methyl Ester Chemical compound COC(=O)C(O)C1=CC=CC=C1 ITATYELQCJRCCK-UHFFFAOYSA-N 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 241000589774 Pseudomonas sp. Species 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical class [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- DHXVGJBLRPWPCS-UHFFFAOYSA-N Tetrahydropyran Chemical compound C1CCOCC1 DHXVGJBLRPWPCS-UHFFFAOYSA-N 0.000 description 1
- 241000179532 [Candida] cylindracea Species 0.000 description 1
- 150000001266 acyl halides Chemical class 0.000 description 1
- 238000005576 amination reaction Methods 0.000 description 1
- 239000003849 aromatic solvent Substances 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- VEMKTZHHVJILDY-UXHICEINSA-N bioresmethrin Chemical compound CC1(C)[C@H](C=C(C)C)[C@H]1C(=O)OCC1=COC(CC=2C=CC=CC=2)=C1 VEMKTZHHVJILDY-UXHICEINSA-N 0.000 description 1
- YZBQHRLRFGPBSL-RXMQYKEDSA-N carbapenem Chemical compound C1C=CN2C(=O)C[C@H]21 YZBQHRLRFGPBSL-RXMQYKEDSA-N 0.000 description 1
- DHSUYTOATWAVLW-WFVMDLQDSA-N cilastatin Chemical compound CC1(C)C[C@@H]1C(=O)N\C(=C/CCCCSC[C@H](N)C(O)=O)C(O)=O DHSUYTOATWAVLW-WFVMDLQDSA-N 0.000 description 1
- 229960004912 cilastatin Drugs 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 229960001760 dimethyl sulfoxide Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- ITATYELQCJRCCK-QMMMGPOBSA-N methyl (2s)-2-hydroxy-2-phenylacetate Chemical compound COC(=O)[C@@H](O)C1=CC=CC=C1 ITATYELQCJRCCK-QMMMGPOBSA-N 0.000 description 1
- 239000012454 non-polar solvent Substances 0.000 description 1
- 229940117803 phenethylamine Drugs 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 229940056729 sodium sulfate anhydrous Drugs 0.000 description 1
- 239000011877 solvent mixture Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- YFDSDPIBEUFTMI-UHFFFAOYSA-N tribromoethanol Chemical compound OCC(Br)(Br)Br YFDSDPIBEUFTMI-UHFFFAOYSA-N 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/02—Amides, e.g. chloramphenicol or polyamides; Imides or polyimides; Urethanes, i.e. compounds comprising N-C=O structural element or polyurethanes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/02—Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/22—Separation; Purification; Stabilisation; Use of additives
- C07C231/24—Separation; Purification
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/57—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C233/58—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
- C12P41/006—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by reactions involving C-N bonds, e.g. nitriles, amides, hydantoins, carbamates, lactames, transamination reactions, or keto group formation from racemic mixtures
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/62—Carboxylic acid esters
Definitions
- the present invention relates to a process for preparing an optically active cyclopropane carboxamide and derivatives thereof by using an enzyme.
- 2,2-dimethylcyclopropanecarboxylic acid is used as a dihydropeptidase I inhibitor and pyrethroids-based insecticides having exceptionally low toxicity to mammals (British Patent No. 1,260,847), and also is a chiral building block which is an important material having a significant industrial meaning in the development of various applications, where it is used as a key intermediate for cilastatin which inhibits the decomposition of a carbapenem-based antibiotic in the kidney (European Patent Specifications EP0048301 and EP0048025) and as an optical resolving reagent.
- the conventional preparation methods can be largely classified into two categories, that is: a method wherein optically active amines, hydroxyl group-containing L- menthol, or (S)-mandelic acid ester is used to prepare an ester, then recrystallization was repeatedly carried out; and a method wherein an (S)-isomer of a product is prepared through a biotrasformation process.
- Both of the two methods have problems such as low optical purity of the product, low yield, use of an expensive reagent for optical resolution and repeated recrystallization; several problems among which are necessarily accompanied. Thus, it can be said that they have industrial limitations.
- 5,166,417 discloses optical resolution by preparing a diastereomer using optically active l-(3-methoxyphenyl)ethylamine and subsequent recrystallization, but requirement of a very expensive chiral amine, low yield of about 21%, optical purity 93% or below of the produced (S)-dimethyl cyclopropane carboxylic acid render it less suitable for commercialization.
- Japanese Published Patent Application No. 80-051023 discloses a process for preparing (S)-dimethyl cyclopropane carboxylic acid by means of optical resolution using quinine, but this method has disadvantages that quinine is very expensive as well as not available stably and besides that the yield is low.
- British Patent No. 1260847 discloses a process using D- or L-phenethylamine for optical resolution, but it has problems that the (S)-dimethyl cyclopropane carboxylic acid produced by this process has an optical purity as low as 49% and that the yield is low, thus it is not good for industrial availability.
- U.S. Pat. No. 5,243,070 discloses a process for preparing dimethylcyclo- propanecarboxamide which comprises preparing a racemate of dimethylcyclo- propanecarboxylic acid ester by reacting dimethylcyclopropanecarboxylic acid with optically active mandelic acid methyl ester, seperating optical isomers by means of re- crystallization of the racemate, hydrolyzing the product to prepare (S)-dimethylcyclopropane carboxylic acid, and performing a resolution of a chiral resolving reagent and isomers.
- This however, has drawbacks that the used (S)-mandelic acid methyl ester is a highly expensive reagent, and at least three times of recrystallization should be repeated in order to increase the optical purity.
- WO 2004/005241 discloses a process for preparing
- Korean Published Patent Application No. 10-2004-0004744 discloses a process for preparing (S)-dimethylcyclopropane carboxamide, which comprises reacting dimethyl- cyclopropane carboxylic acid with alcohol to prepare a racemate of dimethylcy- clopropane carboxylic acid ester, subjecting the product to biological resolution using a microorganism to prepare (S)-dimethylcyclopropane carboxylic acid and (R)-dimethylcyclopropane carboxylic acid, and then further performing addition reacting of the prepared (S)-dimethylcyclopropane carboxylic acid with various chlorinating reagents and ammonia.
- the present inventors have found that when a racemate of cyclopropane carboxylic acid ester is reacted with the lipase from Candida antarctica as an enzyme in an organic solvent having ammonia gas dissolved therein, only an (S)-isomer of substituted cyclopropane carboxylic acid ester specifically participates in the reaction, thereby in the reaction solution an (S)-isomer of cyclopropane carboxamide and an (R)-isomer of cyclopropane carboxylic acid ester is prepared.
- the object of the present invention is to provide an (S)-cyclopropane carboxamide and derivatives thereof with a high optical purity and a high yield, which is industrially economical, by using a hydrolysis enzyme at a high concentration, even without using expensive optical resolving reagents such as conventionally used optically active amines or L- menthol, and without performing complicated biotransformation processes.
- the present invention relates to a novel process for preparing cyclopropane carboxamide and derivatives thereof represented by the following formula 1 (hereinafter, optically active cyclopropane carboxamide) by using an enzyme. More specifically, the present invention relates to a process for preparing optically active cyclopropane carboxamide and cyclopropane carboxylic acid ester, which comprises the steps of (1) reacting a racemate of cyclopropane carboxylic acid ester represented by formula 3 with a lipase from Candida antarctica at a constant reaction temperature in an organic solvent having ammonia gas dissolved therein; and (2) separating (S)-cyclopropane carboxamide represented by formula 1 and (R)-cyclopropane carboxylic acid ester represented by formula 2:
- R and R may be the same or different, and independently represent hydrogen, substituted or unsubstituted straight or branched Cl to C7 alkyl, substituted or un- substituted straight or branched Cl to C7 alkenyl, benzyl, substituted or unsubstituted C3 to C7 cycloalkyl, substituted or unsubstituted arylalkyl, or substituted or unsubstituted heteroarylalkyl;
- R and R may be the same or different, independently represent hydrogen
- R is Cl to C7 straight or branched alkyl, halogen compound-substituted Cl to C7 straight or branched alkyl, or substituted or unsubstituted straight or branched Cl to C7 alkoxy group-substituted Cl to C7 straight or branched alkyl.
- lipases which act as an enzyme in the optical resolution
- examples of the which used include lipases from Candida cylindracea, Pseudomonas sp., Candida rugosa, and Candida antarctica, etc.
- These are different in the kinds of the reactive compounds, the kinds of the reactive optical isomers and the reactivity according to their origin.
- Most of the lipases do not catalyze the reaction of the present invention. Even in the case of partially hydroyzing, low optical purities render the enzyme meaningless.
- the present inventors have found that in the enzymatic optical resolution, only a lipase from Candida antarctic gives a high conversion rate and high optical purity.
- racemate (3) of cyclopropane carboxylic acid ester can be easily prepared by esterification of the racemate (4) of cyclopropane carboxylic acid with various alcohols.
- the reaction mixture having the compound without separating the reaction mixture, to the reaction mixture having the compound, added is at least one alcohol derivative selected from 2-chloroethanol, 2,2-dichloroethanol, 2,2,2-trichloroethanol, 2-fluoroethanol, 2,2-difluoroethanol, 2,2,2-trifluoroethanol, 2-bromoethanol, 2,2-dibromoethanol, 2,2,2-tribromoethanol and 2-methoxyethanol, to produce the racemate (3) of cyclopropane carboxylic acid ester with a high yield of 85% or higher.
- a lipase from Candida antarctica as an enzyme, to perform amination and optical resolution in an organic solvent having ammonia gas dissolved therein.
- the organic solvent is a solvent mixture comprising one or more solvents selected from alcohol solvent such as methanol, ethanol, propanol, isopropanol, butanol, isoamyl alcohol, tert-butanol, pentanol, hexanol, heptanol and octanol; an oxane solvent such as 1,4-dioxane and trioxane; an amide solvent such as diethylformamide and dimethylformamide; dimethylsulf oxide; an aromatic solvent such as benzene, toluene and xylene; and a non-polar solvent such as hexane, heptane, octane, and cy- clohexane.
- alcohol solvent such as methanol, ethanol, propanol, isopropanol, butanol, isoamyl alcohol, tert-butanol, pentanol, hex
- the specific enzymatic optical resolution by the lipase from Candida antarctica according to the present invention can be performed by any carboxylic acid ester compound having cyclopropane carboxylic acid moiety,
- R and R in cyclopropane moiety of formula 1 can be anything.
- R and R may be the same or different, and each are preferably selected form hydrogen, substituted or unsubstituted straight or branched Cl to C7 alkyl, substituted or unsubstituted straight or branched Cl to C7 alkenyl, benzyl, substituted or unsubstituted C3 to C7 cycloalkyl, substituted or unsubstituted arylalkyl, and substituted or unsubstituted heteroarylalkyl.
- R and R are the same or different, and are independently selected from methyl, ethyl, n-propyl, i-propyl, n-butyl, n-pentyl, n-hexyl, fluoromethyl, difluoromethyl or trifluoromethyl. It is still more preferable when both of R and R are methyl.
- the most significant factor which affects the specific enzymatic optical resolution by the lipase from Candida antarctica according to the present invention is the characteristics of the substituents R through R in the racemate of cyclopropane carboxylic acid ester.
- R and R may be the same or different, and each can be selected from hydrogen, substituted or unsubstituted straight or branched Cl to C7 alkyl, substituted or unsubstituted straight or branched Cl to C7 alkenyl, benzyl, substituted or unsubstituted C3 to C7 cycloalkyl, substituted or unsubstituted arylalkyl, and substituted or unsubstituted heteroarylalkyl, and R is can be selected from Cl to C7 straight or branched alkyl.
- R is preferably selected from halogen compound-substituted Cl to C7 straight or branched alkyl, or substituted or unsubstituted straight or branched Cl to C7 alkoxy group-substituted Cl to C7 straight or branched alkyl.
- R and R are each hydrogen, and R is selcted from fluoromethyl, difluoromethyl, trifluoromethyl, chloromethyl, dichloromethyl, trichloromethyl, bromomethyl, di- bromomethyl, tribromomethyl, methoxymethyl, and ethoxymethyl.
- Candida antarctica mentioned above is easily available because it is commercially available.
- the concentration of the lipase from Candida antarctica in the reaction is preferably 1 to 30 parts by weight, based on 100 parts by weight of the racemate of cyclopropane carboxylic acid ester as a substrate, and more preferably about 5 parts by weight. It is preferable to use an enzyme in the immobilized form, for the reaction convenience and economy.
- the specific enzymatic optical resolution of cyclopropane carboxylic acid by a lipase from Candida antarctica according to the present invention is subject to reaction under the reaction temperature maintained constant, wherein the reaction temperature is preferably 10 to 8O 0 C. When considering the optical purity, the reaction temperature of 20 to 45 0 C is the most preferable.
- concentration of the racemate of cyclopropane carboxylic acid ester as a substrate used for the enzymatic optical resolution is suitably 3% to 70%, and when considering the process efficiency, preferably 5% to 40%.
- a simple post-treatment process following the specific enzymatic optical resolution can be carried out to separate optically active cyclopropane carboxamide and cyclopropane carboxylic acid ester.
- the mixed reaction solution is filtered to recover the enzyme, and the organic solvent and low-boiling point organic materials are distilled off from the filtrate, thereby obtaining (S)-2,2-dimethylcyclopropane carboxamide.
- the product is purified by recrystallization in methanol.
- the enzyme used in the enzymatic reaction is isolated by using a filter, etc. after completion of the reaction, and can be reused after washing.
- the preparation process according to the present invention has advantages that it is a novel process for preparing an (S)-cyclopropane carboxamide and derivatives thereof with a high optical purity and a high yield, which is industrially economical, by hy- drolyzing enzyme at a high concentration, even without using expensive optical resolving reagents such as conventionally used optically active amines or L-menthol, and without performing complicated biotransformation processes.
- Mode for the Invention is a novel process for preparing an (S)-cyclopropane carboxamide and derivatives thereof with a high optical purity and a high yield, which is industrially economical, by hy- drolyzing enzyme at a high concentration, even without using expensive optical resolving reagents such as conventionally used optically active amines or L-menthol, and without performing complicated biotransformation processes.
- Candida antarctica Type B lipase As shown in Table 2, after the screening of the enzymes using a racemate of 2,2-dimethylcyclopropane carboxylic acid 2,2,2-trifluoroethyl ester as a substrate, only Candida antarctica Type B lipase (Example 1) leads to a production of the optical isomers of (S)-dimethylcyclopropane carboxamide with a high optical purity to be industrially useful, while other lipases, proteases and esterase did not cause the reactions. Thus, it could be confirmed that the lipase from Candida antarctica, which is a stere- ospecific enzyme, as an enzyme for the preparation process according to the present invention is remarkably effective.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Wood Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
L'invention porte sur un procédé de préparation de cyclopropane carboxamide optiquement actif, dans une structure spécifique utilisant une enzyme.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT0951906A AT509135A1 (de) | 2005-12-12 | 2006-12-12 | Verfahren zur herstellung von optisch aktivem cyclopropancarboxamid und derivaten davon |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020050122129A KR100650797B1 (ko) | 2005-12-12 | 2005-12-12 | 광학활성 사이클로프로판 카복사미드의 제조방법 |
KR10-2005-0122129 | 2005-12-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2007069841A1 true WO2007069841A1 (fr) | 2007-06-21 |
Family
ID=37713941
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2006/005402 WO2007069841A1 (fr) | 2005-12-12 | 2006-12-12 | Procede de preparation de cyclopropane carboxamide optiquement actif, et de ses derives |
Country Status (3)
Country | Link |
---|---|
KR (1) | KR100650797B1 (fr) |
AT (1) | AT509135A1 (fr) |
WO (1) | WO2007069841A1 (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013126337A1 (fr) * | 2012-02-24 | 2013-08-29 | Bristol-Myers Squibb Company | Procédé pour séparer des diesters de cyclopropyle |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100884558B1 (ko) | 2008-09-11 | 2009-02-19 | 디에이치씨 (주) | 고수율 및 고 광학순도의 광학활성 아미드의 제조방법 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5360731A (en) * | 1991-03-06 | 1994-11-01 | Lonza Ltd. | Bacteria capable of stereospecifically hydrolyzing R-(-)-2,2-dimethylcyclopropanecarboxamide |
US5427934A (en) * | 1991-07-26 | 1995-06-27 | Lonza Ltd. | Genetic engineering process for the production of S-(+)-2,2-dimethylcyclopropanecarboxamide by microorganisms |
WO1998029561A1 (fr) * | 1996-12-27 | 1998-07-09 | Smithkline Beecham Plc | Resolution enzymatique d'esters d'acide acetique de benzodiazepine par une lipase |
WO2003083126A2 (fr) * | 2002-03-22 | 2003-10-09 | Dow Global Technologies Inc. | Resolution enzymatique d'esters et d'acetates d'ether de propylene glycol alkyle (ou aryle) |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100511534B1 (ko) * | 2002-07-05 | 2005-08-31 | 임광민 | 아미드 화합물의 새로운 제조방법 |
-
2005
- 2005-12-12 KR KR1020050122129A patent/KR100650797B1/ko not_active Expired - Fee Related
-
2006
- 2006-12-12 WO PCT/KR2006/005402 patent/WO2007069841A1/fr active Application Filing
- 2006-12-12 AT AT0951906A patent/AT509135A1/de not_active Application Discontinuation
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5360731A (en) * | 1991-03-06 | 1994-11-01 | Lonza Ltd. | Bacteria capable of stereospecifically hydrolyzing R-(-)-2,2-dimethylcyclopropanecarboxamide |
US5427934A (en) * | 1991-07-26 | 1995-06-27 | Lonza Ltd. | Genetic engineering process for the production of S-(+)-2,2-dimethylcyclopropanecarboxamide by microorganisms |
WO1998029561A1 (fr) * | 1996-12-27 | 1998-07-09 | Smithkline Beecham Plc | Resolution enzymatique d'esters d'acide acetique de benzodiazepine par une lipase |
WO2003083126A2 (fr) * | 2002-03-22 | 2003-10-09 | Dow Global Technologies Inc. | Resolution enzymatique d'esters et d'acetates d'ether de propylene glycol alkyle (ou aryle) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013126337A1 (fr) * | 2012-02-24 | 2013-08-29 | Bristol-Myers Squibb Company | Procédé pour séparer des diesters de cyclopropyle |
Also Published As
Publication number | Publication date |
---|---|
AT509135A1 (de) | 2011-06-15 |
KR100650797B1 (ko) | 2006-11-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5728876A (en) | Resolution of the racemates of primary and secondary amines by enzyme-catalyzed acylation | |
EP0206436B1 (fr) | Préparation enzymatique d'isomères optiques d'acides 2-halopropioniques | |
JPH10512759A (ja) | 酵素触媒作用アシル化による1級及び2級のヘテロ原子置換アミンのラセミ体分割 | |
KR100452248B1 (ko) | 카비놀분리방법 | |
Toone et al. | Enzymes in organic synthesis. 40. Evaluation of the enantioselectivity of the pig liver esterase catalyzed hydrolyses of racemic piperidine carboxylic acid esters | |
WO2007069841A1 (fr) | Procede de preparation de cyclopropane carboxamide optiquement actif, et de ses derives | |
JP2006510364A (ja) | (r)または(s)体のn−(2,6−ジメチルフェニル)アラニンおよびその逆対掌体であるn−(2,6−ジメチルフェニル)アラニンエステルを、酵素を用いて調製する方法 | |
CA2065433C (fr) | Synthese d'arylalcanediols de grande purete optique | |
EP0890649B1 (fr) | Procédé pour la préparation des esters d'acides aminés acylés et séparation des racemates des esters d'acides aminés par acylation enzymatique | |
JP4843813B2 (ja) | 酵素を用いるR−体又はS−体のα−置換ヘテロサイクリックカルボン酸及びこれと反対鏡像の鏡像異性体のα−置換ヘテロサイクリックカルボン酸エステルの調製方法 | |
KR100650798B1 (ko) | 광학활성 카복실산의 제조방법 | |
US5254756A (en) | Process for the production of (2R,3E)-4-halo-3-buten-2-ols | |
JP3704731B2 (ja) | 光学活性3−ヒドロキシヘキサン酸類の製造方法 | |
WO2001092553A1 (fr) | Procede de resolution optique d'un acide carboxylique heterocyclique alpha-substitue racemique a l'aide d'enzymes | |
US5126267A (en) | Protected hydroxy method for alcohol-ester separation | |
KR100337387B1 (ko) | 키랄 알릴 알콜의 제조방법 | |
EP0556909B1 (fr) | Séparation des énantiomères des esters benzoyliques de 1,2-isopropylidène-glycérol | |
JPH0649005A (ja) | ビニルグリシン(2−アミノ−3−ブテン酸)の簡単な製造方法および誘導体の簡便な分割 | |
US8008062B2 (en) | Production of (R)- and (S)-4-(1-aminoethyl) benzoic acid methyl ester sulfate by lipase acylation of racemic 4-(1-aminoethyl) benzoic acid methyl ester and sulfuric acid precipitation | |
JP2612671B2 (ja) | 光学活性なプロピオン酸エステルの製造法 | |
EP0474861B1 (fr) | Separation d'un alcool et d'un ester par reaction avec de l'acetate | |
US20030148481A1 (en) | Method for kinetic resolution of racemates of alcohols having one or several stereogenic centers | |
DE4414273A1 (de) | Enzymatische Racematspaltung asymmetrischer Alkohole mittels Vinylestern mehrbasiger Carbonsäuren | |
US5573949A (en) | Enzymatic process for the preparation of optically active Tetrahydro-2-naphthoic acids | |
KR100359028B1 (ko) | 키랄 알릴 에스테르의 제조방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 95192006 Country of ref document: AT Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 5919/DELNP/2008 Country of ref document: IN |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 06824108 Country of ref document: EP Kind code of ref document: A1 |